OLUSEGUN ASUBIOJO: Open Payments
NPI 1508444191 · GULF BREEZE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 45 payments from 14 companies in 2025. Trend: 2023 $665 · 2024 $1,053 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $207 |
| Lilly USA, LLC | 12 | $152 |
| PFIZER INC. | 4 | $75 |
| Novo Nordisk Inc | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Amgen Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Philips North America LLC | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: AIRSUPRA, MOUNJARO, NURTEC ODT, XIFAXAN, EVENITY, Ozempic, LEQVIO, JARDIANCE.
Industry payments across FL — which companies pay providers there.
